Biological Description

Specificity ALP Antibody (Rabbit mAb) [J23J16] detects endogenous levels of total ALP proteins.
Background ALP (actinin-associated LIM protein, also called PDLIM3) is a cytoskeletal adaptor protein belonging to the PDZ-LIM family, built from an N-terminal PDZ domain and a C-terminal LIM domain connected by a variable internal region, and it is expressed at high levels specifically in differentiated skeletal muscle, with an alternatively spliced isoform present at lower levels in cardiac muscle. ALP's PDZ domain binds directly to the spectrin-like repeat motifs within the rod domain of alpha-actinin-2, a binding mode distinct from the classical PDZ-domain interactions with C-terminal peptide sequences described for other PDZ proteins, and through this interaction ALP localizes together with alpha-actinin-2 specifically to the Z-lines of striated muscle sarcomeres, the structures that anchor and cross-link actin thin filaments between adjacent sarcomeric units; ALP is not a component of the dystrophin protein complex despite sharing the Z-line and costamere region with dystrophin-associated proteins. Purified ALP protein enhances alpha-actinin's capacity to cross-link actin filaments biochemically, indicating that ALP does not merely dock onto the Z-line but actively augments the actin-bundling function of alpha-actinin at this site. Beyond this structural cytoskeletal role, ALP regulates transcriptional activity of serum response factor, a transcription factor central to muscle gene expression programs, and this transcriptional function requires ALP's physical association with the actin cytoskeleton through its PDZ-domain interaction with alpha-actinin, linking the organization of the sarcomeric cytoskeleton directly to control of muscle differentiation gene expression rather than treating these as separate ALP functions. Because ALP sits at the Z-disc where mechanical tension within the sarcomere is transmitted and sensed, and because its cytoskeletal engagement is required for its effect on serum response factor-driven transcription, ALP is positioned as a mechanotransduction link between sarcomeric structural integrity and the gene expression programs that maintain and remodel striated muscle, and mutations affecting related PDZ-LIM family Z-disc proteins are associated with cardiomyopathy and skeletal myopathy.

Usage Information

Application WB, IP Dilution
WB IP
1:5000 1:200-1:400
Reactivity Human, Mouse, Rat
Source Rabbit Monoclonal Antibody MW 39 kDa
Storage Buffer PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Storage
(from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years
IP
Experimental Procedure:
 
Reagents and Preparation
1. Basic buffers: 1× PBS or 1× TBS (pre-chilled on ice); 1× cell lysis buffer (add 1 mM PMSF protease inhibitor immediately before use; add phosphatase inhibitors for phosphoproteins).
2. Capture medium: Protein A/G magnetic beads or agarose beads (Sepharose beads).
3. Controls: Use an isotype control IgG matching the host species and IgG subclass of the primary antibody, at the same concentration. It is recommended to reserve a portion of the cell lysate that has not been subjected to immunoprecipitation as the Input control; if necessary, a beads-only control (beads added without antibody) may also be included.
4. Loading and elution reagents: 3× or 4× SDS sample loading buffer (containing DTT/reducing agent); if non-denaturing elution is to be performed, prepare the corresponding elution buffer and neutralization buffer separately; for denaturing elution, 1× PBS is typically used to dilute the 3× or 4× SDS sample loading buffer to 1×.
 
Cell Lysis and Sample Preparation (Native Protein Extraction)
1. Cell harvesting: Discard the culture medium and wash the cells once with ice-cold 1× PBS.
2. Cell lysis: Add 0.5–1 mL of ice-cold 1× cell lysis buffer to a 10-cm culture dish and incubate on ice for 5–10 minutes.
3. Lysate collection and clarification: Scrape the cells and transfer the lysate to a microcentrifuge tube. Some adherent cells may require detachment using digestive enzymes or mechanical methods. Centrifuge at 14,000 rpm at 4°C for 5–15 min. Collect the supernatant as the clarified cell lysate. It is recommended to determine the protein concentration.
 
Pre-clearing and Immunoprecipitation Reaction
1. Pre-clearing of the lysate (recommended): Take an appropriate amount of beads (magnetic beads or agarose beads) and pre-wash 2–3 times with cell lysis buffer or 1× TBS/PBS. After pre-washing, it is recommended to remove the wash buffer as completely as possible before adding subsequent reagents, to avoid extra dilution of the sample. For lysis systems containing detergents or specific salt concentrations, prefer pre-washing with a buffer identical or compatible with the lysis buffer to minimize buffer-system mismatches.
2. Pre-clearing treatment: Mix the cell lysate with the pre-washed beads and incubate with rotation at room temperature for 30–60 min, or at 4°C with rotation for 1–2 h.
When using agarose beads, pellet the beads by centrifugation after incubation and collect the supernatant.
When using magnetic beads, separate the beads using a magnetic stand after incubation and collect the supernatant.
This step removes proteins that bind non-specifically to the beads. For unstable proteins, phosphoproteins, or protein complexes, incubation at 4°C is preferred to minimize protein degradation, dephosphorylation, or complex dissociation. Beads used for pre-clearing should generally not be pre-coupled with a specific antibody, to avoid loss of the target antigen.
3. Formation of the “bead–antibody–antigen” immunocomplex
Either of the following two approaches may be used:
3.1 Pre-form the antibody–antigen complex, then add the beads: Add an appropriate amount of primary antibody to the pre-cleared supernatant obtained in step 2, and set up an isotype control IgG group in parallel. Incubate with rotation at 4°C overnight (recommended), or at room temperature with rotation for 2 h, to allow formation of the antibody–antigen complex.
In parallel, take an appropriate amount of beads and pre-wash them as described in step 1 of this section. Add the antibody–antigen complex to the pre-washed magnetic or agarose beads and incubate with rotation at room temperature for 30 min–1 h, or at 4°C with rotation for 1–2 h, to allow the antibody–antigen complex to bind efficiently to the beads.
3.2 Pre-form the bead–antibody complex, then add the cell lysate: Dilute the primary antibody in cell lysis buffer at the dilution ratio recommended in the antibody instruction manual to prepare the antibody working solution. Add an appropriate amount of pre-washed magnetic beads to the antibody working solution and incubate with rotation at room temperature for 15 min, or at 4°C with rotation for 1 h, to form the bead–antibody complex.
Recover the beads by magnetic separation or centrifugation, discard the supernatant, and pre-wash the beads 2–3 times with 1× TBS. Then add the cell lysate and incubate with rotation at 4°C overnight (recommended), or at room temperature with rotation for 2 h.
 
Washing of the Precipitate and Sample Elution
1. Once immunoprecipitation is complete, separate the beads according to their type and discard the supernatant.
Magnetic beads are separated using a magnetic stand.
For agarose beads, low-speed centrifugation (500–1000 rpm) appropriate for the bead specifications should be used, to avoid bead compaction or damage caused by high-speed centrifugation.
2. Washing the beads: Gently wash the beads 3–5 times with ice-cold 1× cell lysis buffer or 1× TBS/TBST. Keep the temperature low throughout the washes. After each addition of wash buffer, mix gently to fully resuspend the beads; then separate the beads using a magnetic stand or appropriate centrifugation, depending on the bead type, and remove the wash buffer thoroughly to minimize unbound and non-specifically bound components. During each wash, remove as much supernatant as possible while avoiding aspiration of the beads. After the final wash, remove residual wash buffer as completely as possible to prevent dilution of the eluate or interference with downstream analyses. Keep the samples on ice after each wash.
3. Sample elution (choose one of the following):
3.1 Denaturing direct elution (most commonly used): Add SDS sample loading buffer to the bead pellet to a final concentration of 1×. If 3× or 4× SDS sample loading buffer is used, it must first be diluted to 1×. Mix well and heat at 95–100°C for 5 minutes. Separate the beads and collect the supernatant for subsequent electrophoresis.
3.2 Chemical / non-denaturing elution (preserves protein activity): After the final wash, separate the beads using a magnetic stand or low-speed centrifugation, depending on the bead type, and remove residual wash buffer as completely as possible to prevent dilution of the eluate. Add an appropriate amount of acidic elution buffer / high-salt elution buffer to the beads and resuspend them thoroughly. Mix gently and incubate briefly at room temperature to allow the immunocomplex to dissociate from the beads. Separate the beads with a magnetic stand or low-speed centrifugation, and transfer the eluate to a collection tube pre-filled with an appropriate amount of neutralization buffer; adjust the pH if necessary. To improve recovery, elution may be repeated and the eluates pooled. The composition and volume of the elution buffer and neutralization buffer should be determined according to the instructions for the beads and kit used.
3.3 Post-elution sample handling
For protein activity assays, native protein complex analysis, or other non-denaturing analyses: do not add SDS sample loading buffer; keep the sample on ice and proceed to the subsequent experiment as quickly as possible.
For SDS-PAGE or Western blot: add SDS sample loading buffer to the neutralized or desalted eluate to a final concentration of 1×, and then process the sample according to the subsequent electrophoresis requirements.
Select appropriate storage conditions according to the stability of the target protein and the requirements of downstream experiments, and avoid repeated freeze–thaw cycles.
 
Downstream Analysis
Western blot analysis: Take the supernatant and perform SDS-PAGE electrophoresis followed by membrane transfer. It is recommended to use light- and heavy-chain-specific or conformation-specific secondary antibodies to avoid interference of the immunoglobulin heavy/light chain bands (50 kDa / 25 kDa) with detection of the target protein. It is recommended to include Input, isotype control IgG-IP, and target antibody-IP samples on the same Western blot; if necessary, a beads-only control may also be added to evaluate immunoprecipitation efficiency and non-specific binding. Kinase activity assay (if applicable): skip the denaturation step, wash the beads with kinase buffer, then add substrate and ATP directly to perform the kinase reaction.
 

Note: All lysis and immunoprecipitation procedures should be performed at 4°C or on ice to preserve the native conformation of proteins as much as possible and prevent their degradation.

References

  • https://pubmed.ncbi.nlm.nih.gov/9334352/
  • https://pubmed.ncbi.nlm.nih.gov/17332502/

Application Data